Randal Kirk J.D. Intrexon Corporation CEO Rating

Intrexon Corporation CEO Randal Kirk J.D. Bio

Mr. Randal J. Kirk, also known as RJ, J.D., has been the Chief Executive Officer of Intrexon Corporation since April 2009. Mr. Kirk served as President of Intrexon Corporation since April 2009. He served as Acting President of Human Therapeutics Division at Intrexon Corporation until June 2011. Mr. Kirk serves as a Senior Managing Director, Chief Executive Officer and Chairman of Third Security, LLC. He founded the firm in March 1999. Mr. Kirk has been a Manager at New River Management Company, LLC since 1996. He served as the President and Chief Executive Officer at New River Pharmaceuticals Inc. from October 2001 and April 2007. Mr. Kirk founded New River Pharmaceuticals Inc. in 1996. He began his professional career in the private practice of law. Mr. Kirk co-founded General Injectables & Vaccines, Inc. in 1984. He also co-founded King Pharmaceuticals, Inc. in 1993. He has been the Chairman of the Board at New River Pharmaceuticals Inc. since 1996 and a Director since August 1996. He has been the Chairman of Landmark Scientific, Inc. since 1996. Mr. Kirk serves as the Chairman of Biological & Popular Culture LLC since September 2002 and the Chairman of its predecessor from October 1999 to September 2002. He has been the Chairman of Intrexon Corporation since February 2008 and Cyntellect Inc. since September 2008. He is a member of the Board of Directors of the Edward Via College of Osteopathic Medicine since May 2015. He has been a Director of Michael W. Cook Asset Management, Inc. since January 2003. He has been a Director of Intrexon Corporation since 2008. He has been a Director at Harvest Pharmaceuticals Inc. since December 2002 and ZIOPHARM Oncology, Inc. since January 12, 2011. He has been an Independent Director of Halozyme Therapeutics, Inc. since May 2007. He has served on the Virginia Bioinformatics Institute Policy Advisory Board since March 2004. He served as the Chairman of Board for Clinical Data since December 16, 2004 and April 2011. Mr. Kirk served as the Chairman of the Board at GIV prior to the sale of that company in 1998. Mr. Kirk served as the Director of Clinical Data from September 2002 to April 2011. He served as a Director of Scios Inc. from February 2000 until his resignation on May 15, 2002 and Howe and Rusling, Inc. from December 2001 to 2006. He was on the Governor's Economic Development and Jobs Creation Commission from April 2010 to October 2012. He had been a Member to the Board of Visitors at University of Virginia and Affiliated Schools from July 20, 2009 to October 2012. He served as a member of the Board of Directors of the Virginia University Research Partnership from July 2007 to November 2010. Mr. Kirk served on the Board of Visitors of Radford University since July 2003 to June 2009 and was elected Rector of the Board from September 2006 to September 2008. He Kirk served as a Director of the Radford University Foundation, Inc. from September 1998 to May 2011. He was appointed to the Virginia Advisory Council on Revenue Estimates from July 2006 to October 2012. Mr. Kirk received a JD from the University of Virginia and a BA in Business from Radford University.

Intrexon Corporation CEO Randal Kirk J.D. At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Intrexon Corporation.

Intrexon Corporation's CEO is highly regarded by Male employees. Overall, the CEO score has remained stable over the last 90 days.